EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT (this "Agreement") is dated as of the 4th day of October, 2001, and is by and between Senesco, Inc., a New Jersey corporation with an office for purposes of this Agreement at 303...Employment Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • New Jersey
AGREEMENT ---------Registration Rights Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.Eloxx Pharmaceuticals, Inc. • November 13th, 2023 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 19, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 380,590 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 6th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December ____, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 29th, 2010 • Senesco Technologies Inc • Services-commercial physical & biological research
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 26, 2010, between Senesco Technologies Inc., a Delaware corporation (the “Company”), and each of the purchasers who are signatories hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT ------------------------------------------------------Senesco Technologies Inc • May 9th, 2002 • Services-commercial physical & biological research • New Jersey
WARRANT -------Senesco Technologies Inc • January 2nd, 2002 • Services-commercial physical & biological research • Delaware
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement ("Agreement") is made as of October 4, 2001 by and between Senesco Technologies, Inc., a Delaware corporation (the "Company"), and Bruce C. Galton ("Indemnitee")....Indemnification Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • New Jersey
AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT This AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT (the "Amendment") is dated as of February 12, 2004, by and among Senesco Technologies, Inc., a Delaware corporation (the "Company"), and those...Registration Rights Agreement • February 13th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
1. Payments. Subject to Section 2 hereof, all principal and interest due -------- hereunder shall be payable in one (1) installment on October 22, 1999 (the "Maturity Date"); provided, however, that the parties may -------- ------- mutually agree to...Nava Leisure Usa Inc • May 24th, 1999 • Blank checks • New Jersey
AGREEMENT ---------Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
1.1 THE LOAN. Subject to the terms of this Agreement, the Company shall borrow from the Lender and the Lender shall lend to the Company up to Two Hundred Two Thousand Dollars ($202,000) (the "Loan") pursuant to a promissory note in the form attached...Loan Agreement • May 24th, 1999 • Nava Leisure Usa Inc • Blank checks • New Jersey
AGREEMENT ---------Registration Rights Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECTION ICommon Stock Purchase Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
SECTION ISecurities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
PRE-FUNDED COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.Eloxx Pharmaceuticals, Inc. • January 25th, 2024 • Biological products, (no disgnostic substances)
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, SD MF 4 LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 471,508 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
November 28, 2003 Michael C. Caska, President Sands Brothers International, Ltd. 90 Park Avenue New York, New York 10016 Ronald Stein, Senior Vice President Investment Banking/Capital Markets Stanford Group Company 201 South Biscayne Boulevard Suite...Letter Agreement • February 17th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research
Warrant No. Number of Shares: ----- --------- (subject to adjustment) Date of Issuance: , 2004 ------------ Original Issue Date (as defined in subsection 2(a)): , 2004 -------------Senesco Technologies Inc • February 3rd, 2004 • Services-commercial physical & biological research • Delaware
Warrant No.[ ] Number of Shares:[ ] (subject to adjustment) Date of Issuance: [ ]Senesco Technologies Inc • February 14th, 2002 • Services-commercial physical & biological research • New Jersey
SECTION ISecurities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT This AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (this "Amendment"), dated as of February 12, 2004, by and among Senesco Technologies, Inc., a Delaware corporation (the "Company"), and those...Securities Purchase Agreement • February 13th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 18, 2023, between Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF COMMON STOCK WARRANT AGREEMENTWarrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 1st, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 30, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
AGREEMENT ---------Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
WARRANT -------Senesco Technologies Inc • January 2nd, 2002 • Services-commercial physical & biological research • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 29th, 2010 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 26, 2010, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
ELOXX PHARMACEUTICALS, INC. Shares of Common Stock ($0.01 par value per share) SALES AGREEMENTSales Agreement • May 24th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Eloxx Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (the “Agent”), as follows:
EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT (this "Agreement") is dated as of the 1st day of July, 2003, and is by and between Senesco, Inc., a New Jersey corporation with an office for purposes of this Agreement at 303 George...Employment Agreement • September 29th, 2003 • Senesco Technologies Inc • Services-commercial physical & biological research • New Jersey
GRAPHIC OMITTED] April 18, 2002 Bruce C. Galton President and CEO SENESCO TECHNOLOGIES, INC. 303 George Street Suite 420 New Brunswick, NJ 08901 Dear Bruce: This letter shall serve to confirm our agreement as follows: 1. SENESCO TECHNOLOGIES, INC....Senesco Technologies Inc • May 9th, 2002 • Services-commercial physical & biological research
COMMON STOCK PURCHASE WARRANT Senesco Technologies, Inc.Senesco Technologies Inc • December 12th, 2013 • Services-commercial physical & biological research
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December ___, 2013 (the “Initial Exercise Date”) and on or prior to the close of business on the sixth month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Senesco Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECTION ISecurities Purchase Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT ------------------------------------------------------Senesco Technologies Inc • May 9th, 2002 • Services-commercial physical & biological research • New Jersey
ELOXX PHARMACEUTICALS, INC. and [•], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENTWarrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
September 25, 2003 237,600 (b) Exercise for Cash. The Registered Holder may, at its option, ------------------ elect to exercise this Warrant, subject to the Vesting Schedule, in whole or in part and at any time or from time to time, by surrendering...Senesco Technologies Inc • November 14th, 2003 • Services-commercial physical & biological research • New Jersey
